223 related articles for article (PubMed ID: 32768966)
1. Marine compounds targeting the PI3K/Akt signaling pathway in cancer therapy.
Wei J; Gou Z; Wen Y; Luo Q; Huang Z
Biomed Pharmacother; 2020 Sep; 129():110484. PubMed ID: 32768966
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
Polivka J; Janku F
Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
[TBL] [Abstract][Full Text] [Related]
3. Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents.
Sun H; Wang Z; Yakisich JS
Anticancer Agents Med Chem; 2013 Sep; 13(7):1048-56. PubMed ID: 23293890
[TBL] [Abstract][Full Text] [Related]
4. PI3K and AKT: Unfaithful Partners in Cancer.
Faes S; Dormond O
Int J Mol Sci; 2015 Sep; 16(9):21138-52. PubMed ID: 26404259
[TBL] [Abstract][Full Text] [Related]
5. PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes.
Pal I; Mandal M
Acta Pharmacol Sin; 2012 Dec; 33(12):1441-58. PubMed ID: 22983389
[TBL] [Abstract][Full Text] [Related]
6. Targeting the phosphatidylinositol 3-kinase/AKT pathway for the treatment of multiple myeloma.
Zhu J; Wang M; Cao B; Hou T; Mao X
Curr Med Chem; 2014; 21(27):3173-87. PubMed ID: 24934342
[TBL] [Abstract][Full Text] [Related]
7. Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications.
Zarneshan SN; Fakhri S; Farzaei MH; Khan H; Saso L
Food Chem Toxicol; 2020 Nov; 145():111714. PubMed ID: 32871194
[TBL] [Abstract][Full Text] [Related]
8. The PI3K/AKT Pathway as a Target for Cancer Treatment.
Mayer IA; Arteaga CL
Annu Rev Med; 2016; 67():11-28. PubMed ID: 26473415
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
[TBL] [Abstract][Full Text] [Related]
10. Recent development in targeting PI3K-Akt-mTOR signaling for anticancer therapeutic strategies.
Qazi AK; Hussain A; Hamid A; Qurishi Y; Majeed R; Ahmad M; Najar RA; Bhat JA; Singh SK; Zargar MA; Ali S; Saxena AK
Anticancer Agents Med Chem; 2013 Dec; 13(10):1552-64. PubMed ID: 23438828
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy.
Chen YL; Law PY; Loh HH
Curr Med Chem Anticancer Agents; 2005 Nov; 5(6):575-89. PubMed ID: 16305480
[TBL] [Abstract][Full Text] [Related]
12. Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer.
Fumarola C; Bonelli MA; Petronini PG; Alfieri RR
Biochem Pharmacol; 2014 Aug; 90(3):197-207. PubMed ID: 24863259
[TBL] [Abstract][Full Text] [Related]
13. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Singh SS; Yap WN; Arfuso F; Kar S; Wang C; Cai W; Dharmarajan AM; Sethi G; Kumar AP
World J Gastroenterol; 2015 Nov; 21(43):12261-73. PubMed ID: 26604635
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway.
Zhang H; Jiang H; Zhang H; Liu J; Hu X; Chen L
Eur J Pharmacol; 2019 Sep; 858():172477. PubMed ID: 31228450
[TBL] [Abstract][Full Text] [Related]
15. Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy.
Mirza-Aghazadeh-Attari M; Ekrami EM; Aghdas SAM; Mihanfar A; Hallaj S; Yousefi B; Safa A; Majidinia M
Life Sci; 2020 Aug; 255():117481. PubMed ID: 32135183
[TBL] [Abstract][Full Text] [Related]
16. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.
Ji Y; Di W; Yang Q; Lu Z; Cai W; Wu J
Clin Lab; 2015; 61(8):1043-51. PubMed ID: 26427150
[TBL] [Abstract][Full Text] [Related]
18. PI3K/Akt signaling in osteosarcoma.
Zhang J; Yu XH; Yan YG; Wang C; Wang WJ
Clin Chim Acta; 2015 Apr; 444():182-92. PubMed ID: 25704303
[TBL] [Abstract][Full Text] [Related]
19. Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer.
Bitting RL; Armstrong AJ
Endocr Relat Cancer; 2013 Jun; 20(3):R83-99. PubMed ID: 23456430
[TBL] [Abstract][Full Text] [Related]
20. MAPK signaling pathway-targeted marine compounds in cancer therapy.
Wei J; Liu R; Hu X; Liang T; Zhou Z; Huang Z
J Cancer Res Clin Oncol; 2021 Jan; 147(1):3-22. PubMed ID: 33389079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
